Bernadette S. Jager
Duesseldorf, NW 40225, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Real-world insights into bone marrow carcinomatosis in metastatic breast cancer: a retrospective analysis from two large university breast cancer centers.
Journal: Journal of cancer research and clinical oncology
Published: May 09, 2026
Spectrum of double heterozygosity in individuals diagnosed with hereditary breast and ovarian cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 24, 2026
Genetic Testing and Imaging in Men with Familial History or Genetic Predisposition of Prostate Cancer-Introducing the Prospective "ProFam-Risk" Study.
Journal: European urology open science
Published: December 23, 2025
Motivations and experiences of high-risk men in risk-adapted prostate cancer early detection: A qualitative study.
Journal: Patient education and counseling
Published: November 25, 2025
Psychosocial outcomes of risk-adapted prevention for prostate cancer predisposition: study protocol for a longitudinal observational mixed-methods study.
Journal: BMJ open
Published: July 20, 2025
Circulating Tumor DNA in Early and Metastatic Breast Cance-Current Role and What Is Coming Next.
Journal: Cancers
Published: September 15, 2024
Determination of the androgen receptor status of disseminated tumor cells in primary breast cancer patients.
Journal: Archives of gynecology and obstetrics
Published: May 27, 2023
Whole Exome Analysis to Select Targeted Therapies for Patients with Metastatic Breast Cancer - A Feasibility Study.
Journal: Geburtshilfe und Frauenheilkunde
Published: April 30, 2023
Impact of surgical variables on residual glandular tissue in risk-reducing mastectomies: Results of a retrospective monocentric study from a center of the German consortium for hereditary breast and ovarian cancer.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: April 24, 2023
Efficacy of Lapatinib in Patients with HER2-Negative Metastatic Breast Cancer and HER2-Positive Circulating Tumor Cells-The DETECT III Clinical Trial.
Journal: Clinical chemistry
Published: February 03, 2023
Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study program.
Journal: ESMO open
Published: August 04, 2021
Last Updated: 09/26/2026